Dear Colleagues,
The Committee on Patient Protection is pleased to share with you our Society’s Position Statement on the Safety of Fluorescein Angiography on Patients with Kidney Disease.
This recommendation aims to highlight the safety of fluorescein angiography, a common diagnostic procedure done in patients with retinopathy, in relation to Contrast-Associated AKI (CA-AKI). The creation of this position statement has been a long time coming, with new guidelines on CA-AKI released in recent years. Local studies and data have also been emerging, strengthening our available evidence.
Together with our Ophthalmology colleagues, we hope this guide will improve the care of our CKD patients needing fluorescein angiography, with the goal of lessening procedural delays and costs.
The Committee on Patient Protection
Link: Position Statement on the Safety of Fluorescein Angiography on Patients with Kidney Disease
